Ayudando en el proceso de recuperacin despus de lesiones y cirugas
10.1016/j.biopha.2023.114897 52 LuS
Key findings from clinical trials include: Reductions in waist circumference, an indirect marker of abdominal fat Improvements in metabolic markers associated with visceral adiposity (HbA1c, lipid profiles, liver enzymes) Decreased hepatic fat content in patients with fatty liver disease It is important to understand that GLP-1 medications do not 'burn' fat through thermogenesis or direct lipolysis
This once-daily pill contains 25 mg of semaglutide, the same active ingredient found in the weekly Wegovy injection, and works by mimicking the GLP-1 hormone to suppress appetite and regulate blood sugar
While direct endometriosis trials are minimal, these anti-inflammatory mechanisms suggest GLP-1s could theoretically support metabolic and immune stability in women with endometriosisthough clinical evidence remains preliminary and requires provider guidance
Weight loss unloads the heart